Australia New Zealand IBD Consortium (ANZIBDC)
@ANZIBDC
Australia New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC) - Improving Quality of Care and Patient outcomes in Inflammatory Bowel Disease
Discovery of a major underpinning of inflammatory bowel disease in a gene desert nature.com/articles/s4158… @Nature @TheCrick
Clinical trials are more than just a research process—they are a lifeline for patients living with chronic conditions like IBD. At ANZIBDC, we’re proud to support IBD research that improves outcomes & quality of life. #ClinicalTrials #IBD #ANZIBDC #ResearchMatters

We are pleased to share the clinical results of the PREDICT-UC study investigating infliximab dose strategies in ASUC. Thank you to @LancetGastroHep for sharing our research. The full paper can be freely accessed via this link sciencedirect.com/science/articl… @DrChrisLi @Austin_Health
Thanks Dr Hugh Giddings for presenting the results of the PORSCIA study looking at Post operative recurrence and outcomes following Crohn's ileocolic resection. Great collaborative study across Australia.



Great talk by Prof Murray Barclay on therapeutic drug monitoring in gastroenterology. Looking forward to your ongoing work and research with the consortium in this area.


A huge congratulations to Prof Jane Andrews for winning the distinguished researcher prize award at AGW. Your contribution to research in IBD and inclusion of multidisciplinary, patient focused research and improving quality of care has been instrumental in the IBD space!


AGW 2024 - public lecture on Gut Health this Friday! See link below, and register to attend! gesa.eventsair.com/gesa-agw-2024/
IBD Fellow position at Royal Adelaide Hospital 2025. Applications open now! Check out the link below for the chance to work in a dynamic, large, research focussed tertiary IBD Service with a great team! sahealth.sa.gov.au/wps/wcm/connec…
Primary Sclerosing Cholangitis is a chronic progressive disease frequently associated with inflammatory bowel disease (IBD). Hear from experts on PSC including ANZIBDC's @DocKateLynch.
Extraordinary ELPA High-Level Roundtable Discussion on this #GlobalPSCDay Unlock the Secrets of PSC Symptoms, Treatment & Life with Leaders like Sindee Weinbaum, Mary Pressley Vyas, Prof. Dr. Doug Thorburn, Dr. Kate Lynch, and Prof. Dr. Thomas Vanwolleghem youtu.be/CYLpF-HAkAk
Extraordinary ELPA High-Level Roundtable Discussion on this #GlobalPSCDay Unlock the Secrets of PSC Symptoms, Treatment & Life with Leaders like Sindee Weinbaum, Mary Pressley Vyas, Prof. Dr. Doug Thorburn, Dr. Kate Lynch, and Prof. Dr. Thomas Vanwolleghem youtu.be/CYLpF-HAkAk
Amazing work by the PICCOLO team for their work in IBD and pregnancy. Thiopurines associated with increased risk of ICP in IDB pregnancies. @RalleyP @SallyBell_IBD


Astrid on transition care in #IBD #AGW2023

Final Day of #AGW2023. #ANZIBDC finishing strong with talks from our members #AstridWilliams, @RalleyP Prentice, #RichardFernandes, @Gastro_Ash Srinivasan and @DrYoonAn.

#AGW2023 networking at gala dinner after full day of high quality presentations




Very proud of the RAH IBD team presenting work on our experience of Crohn’s Disease Exclusion Diet in Crohn’s disease! #AGW2023
Today I was privileged to present the preliminary results of the ANZ-ASUC study and receive valuable insights from international and national experts in the field. Thank you to all the collaborators and my mentors Dr Yoon-Kyo An and A/Prof Jake Begun.
I am left inspired and thrilled for the future of #intestinalultrasound after seeing the work done in Australia by @GENIUS_health1. Huge honor to share the U.S @iUSCAN progress. Pts & colleagues, IUS is moving the field to a new era of more rapid management & improved outcomes
Intestinal ultrasound training and practice growing worldwide. Looking forward to ongoing collaborations with @iUSCAN . Thanks @KrugCleveland for bringing the US experience to GENIUS and #AGW2023.
Great presentation by #RichardFernandes on ASUC study with ANZIBDC cohort. 5-ASAs, biologics and steroids on discharge seem to be protective against 1 year colectomy regardless of corticosteroid response.
